-12.2%
DASH vs MRNA
+787.6%
-799.8%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.2% | -7.0% | +3.8% | -2.9% |
| 7D | -4.1% | -4.2% | +0.1% | -3.9% |
| 30D | -10.6% | +7.0% | -17.6% | -10.8% |
| 3M | -18.8% | +263.4% | -282.1% | -23.3% |
| 6M | +11.2% | +334.3% | -323.1% | +0.6% |
| YTD | -23.8% | +684.5% | -708.3% | -37.5% |
| 1Y | -12.2% | +766.2% | -778.3% | -29.9% |
| All | -12.2% | +787.6% | -799.8% | -29.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling